Trades on 1 secondary market

Unlearnai

Unlearn.AI provides an AI-powered platform that streamlines clinical trial development using digital twins of patients and advanced data analytics. Its TrialPioneer workspace spans trial planning and simulation (Scout literature search, Hindsight data exploration, SimLab scenario modeling), advanced

emerging 19.4 / 100 0 APIs View provider profile →
CompanyHealthcareClinical TrialsDigital TwinsArtificial IntelligenceMachine Learning

Unlearnai is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.